The {pharmaceutical industry is increasingly exploring alternative treatment strategies for weight management , and the emergence of semaglutide 10mg doses represents a advancement . Clinicians are now evaluate the likely benefits and drawbacks associated with this increased strength formulation , particularly in contrast with existing lower-dose s